MGNX Stock Analysis: Buy, Sell, or Hold?
MGNX - MacroGenics, Inc.
$4.53
0.29 (6.84%)
▲
5d:
+6.59%
30d:
+42.45%
90d:
+158.86%
HOLD
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When MGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MGNX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: MGNX is 13.0% above its trading range ($4.01). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: MGNX is 13.0% above its trading range ($4.01). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: MGNX is currently trading at $4.53, which is considered extended relative to its 30-day fair value range of $2.99 to $4.01.
Technical Outlook: Technically, MGNX is in a strong uptrend. The price is approaching resistance at $4.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: MGNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.75 (+49.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MGNX is in a strong uptrend. The price is approaching resistance at $4.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: MGNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.75 (+49.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.99 -
$4.01
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+13.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 49.0% below Wall St target ($6.75)
Trading Range Analysis
30-Day Trading Range
$2.99 -
$4.01
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.90
Resistance Level
$4.64
Current Trend
Strong Uptrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.21
Wall Street Target
$6.75
(+49.0%)
Revenue Growth (YoY)
57.5%
Earnings Growth (YoY)
-70.4%
Profit Margin
-44.8%
Share & Embed Analysis
Last updated: May 26, 2026 6:36 AM ET
Data refreshes hourly during market hours. Next update: 7:36 AM
Data refreshes hourly during market hours. Next update: 7:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$446 | 62 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1023 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 54 HOLD |
